Orderdjup
Allmän information
Årlig avgift
Tillgångsklass
AktierKategori
Branschfond, läkemedelBasvaluta
EURUtdelningspolicy
ÅterinvesterandeFaktablad
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
Relaterade ETF:er
Exponering
Fördelning
- Aktier99,8%
- Kort ränta0,2%
Kunder har även besökt
Forum
Nyheter
Allmän information
Årlig avgift
Tillgångsklass
AktierKategori
Branschfond, läkemedelBasvaluta
EURUtdelningspolicy
ÅterinvesterandeFaktablad
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
Relaterade ETF:er
Nyheter
Orderdjup
Exponering
Fördelning
- Aktier99,8%
- Kort ränta0,2%
Kunder har även besökt
Forum
Allmän information
Årlig avgift
Tillgångsklass
AktierKategori
Branschfond, läkemedelBasvaluta
EURUtdelningspolicy
ÅterinvesterandeFaktablad
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
Relaterade ETF:er
Nyheter
Forum
Orderdjup
Exponering
Fördelning
- Aktier99,8%
- Kort ränta0,2%
